Evaluation of the cell viability of human Wharton's jelly stem cells for use in cell therapy
- PMID: 22166141
- PMCID: PMC3358099
- DOI: 10.1089/ten.TEC.2011.0508
Evaluation of the cell viability of human Wharton's jelly stem cells for use in cell therapy
Abstract
Human umbilical cord Wharton's jelly stem cells (HWJSCs) are gaining attention as a possible clinical source of mesenchymal stem cells for cell therapy and tissue engineering due to their high accessibility, expansion potential, and plasticity. We employed a combination of highly sensitive techniques to determine the average cell viability levels and proliferation capabilities of 10 consecutive cell passages of cultured HWJSCs and then used RNA microarrays to identify genes associated with changes in cell viability levels. We found an initial decrease in cell viability from the first to the third cell passage followed by an increase until the sixth passage and a final decrease from the sixth to tenth cell passages. The highest cell viability levels corresponded to the fifth and sixth passages. The intracellular ionic contents of potassium, sodium, and chlorine suggest that the lower cell viability levels at passages 2, 3, and 8-10 may be associated with apoptotic cell death. In fact, gene expression analysis revealed that the average cell viability was significantly associated with genes with a function in apoptotic cell death, especially pro-apoptotic FASTKD2, BNIP3L genes and anti-apoptotic TNFAIP8 and BCL2L2 genes. This correlation with both pro-apoptotic and anti-apoptotic genes suggests that there may be a complex live-death equilibrium in cultured HWJSCs kept in culture for multiple cell passages. In this study, the highest cell viability levels corresponded to the fifth and sixth HWJSC passages, suggesting that these passages should be preferentially employed in cell therapy or tissue engineering protocols using this cell type.
Figures





Similar articles
-
Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo.J Cell Biochem. 2012 Feb;113(2):658-68. doi: 10.1002/jcb.23395. J Cell Biochem. 2012. PMID: 21976004
-
Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.BMC Biotechnol. 2012 May 4;12:18. doi: 10.1186/1472-6750-12-18. BMC Biotechnol. 2012. PMID: 22559872 Free PMC article.
-
Freezing of Fresh Wharton's Jelly From Human Umbilical Cords Yields High Post-Thaw Mesenchymal Stem Cell Numbers for Cell-Based Therapies.J Cell Biochem. 2016 Apr;117(4):815-27. doi: 10.1002/jcb.25375. Epub 2015 Sep 17. J Cell Biochem. 2016. PMID: 26365815
-
Wharton's Jelly stem cells: future clinical applications.Placenta. 2011 Oct;32 Suppl 4:S311-5. doi: 10.1016/j.placenta.2011.06.010. Epub 2011 Jul 6. Placenta. 2011. PMID: 21733573 Review.
-
Regenerative potential of Wharton's jelly-derived mesenchymal stem cells: A new horizon of stem cell therapy.J Cell Physiol. 2020 Dec;235(12):9230-9240. doi: 10.1002/jcp.29810. Epub 2020 Jun 18. J Cell Physiol. 2020. PMID: 32557631 Review.
Cited by
-
In Vivo Stem Cell Imaging Principles and Applications.Int J Stem Cells. 2023 Nov 30;16(4):363-375. doi: 10.15283/ijsc23045. Epub 2023 Aug 30. Int J Stem Cells. 2023. PMID: 37643761 Free PMC article. Review.
-
High Sensitivity of Human Adipose Stem Cells to Differentiate into Myofibroblasts in the Presence of C. aspersa Egg Extract.Stem Cells Int. 2017;2017:9142493. doi: 10.1155/2017/9142493. Epub 2017 Dec 27. Stem Cells Int. 2017. PMID: 29445405 Free PMC article.
-
Different isolation methods alter the gene expression profiling of adipose derived stem cells.Int J Med Sci. 2014 Mar 6;11(4):391-403. doi: 10.7150/ijms.7697. eCollection 2014. Int J Med Sci. 2014. PMID: 24669199 Free PMC article.
-
Wharton's jelly-derived mesenchymal cells as a new source for the generation of microtissues for tissue engineering applications.Histochem Cell Biol. 2018 Oct;150(4):379-393. doi: 10.1007/s00418-018-1685-6. Epub 2018 Jun 11. Histochem Cell Biol. 2018. PMID: 29931444
-
Combined Placental Mesenchymal Stem Cells with Guided Nanoparticles Effective Against Diabetic Nephropathy in Mouse Model.Int J Nanomedicine. 2024 Jan 26;19:901-915. doi: 10.2147/IJN.S446733. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38293609 Free PMC article.
References
-
- Alaminos M. Perez-Kohler B. Garzon I. Garcia-Honduvilla N. Romero B. Campos A. Bujan J. Transdifferentiation potentiality of human Wharton's jelly stem cells towards vascular endothelial cells. J Cell Physiol. 2010;223:640. - PubMed
-
- Wu K.H. Zhou B. Lu S.H. Feng B. Yang S.G. Du W.T. Gu D.S. Han Z.C. Liu Y.L. In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J Cell Biochem. 2007;100:608. - PubMed
-
- Chang Y.S. Oh W. Choi S.J. Sung D.K. Kim S.Y. Choi E.Y. Kang S. Jin H.J. Yang Y.S. Park W.S. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplant. 2009;18:869. - PubMed
-
- Can A. Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells. 2007;25:2886. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials